FNCA

Cyclotron and PET in medicine workshop

MENU
photo
Project Review

Introduction of
the Project Leaders


Guideline
"Radiation Protection and Performance Evaluation of PET-CT Imaging"
"Quality Assurance and Quality Control of 18F-FDG"

Workshop
FY2010
FY2009
FY2008
FY2007
FY2006

FNCA 2008 Workshop on Cyclotron and Positron Emission Tomography (PET) in Medicine


Report of
FNCA2008 Workshop
on Cyclotron and Positron Emission Tomography (PET) in Medicine
Jan. 6-9, 2009 Kuala Lumpur, Malaysia

Background:

The third FNCA Workshop on Cyclotron and PET in Medicine was held from January 6 to 9, 2009, at Kuala Lumpur that is the capital city of Lead Country of this project, Malaysia. It was jointly organized by Malaysian Nuclear Agency (Nuclear Malaysia), Ministry of Science, Technology and Innovation, Malaysia (MOSTI) and Ministry of Education, Culture, Sports, Science & Technology of Japan (MEXT). The workshop was attended by delegates from 7 FNCA countries namely People's Republic of China, Indonesia, Japan, Malaysia, The Philippines, Thailand and Vietnam. The participants of workshop amounted to 29 persons.

The objectives of this project are
- Improvement of diagnostic technique for nuclear medicine in Asian countries.
- Early detection with advanced technology such as PET and PET/CT, contributes to human health in Asia.

The themes of three areas namely “Imaging instrumentation”, “Radiation safety and PET radiopharmaceuticals” and “Clinical diagnosis” were considered through their small-group discussion respectively at the workshop.

Participants of Workshop
Participants of Workshop

Group 1 - Imaging Instrumentation

The theme for Group 1 is radiation safety, quality assurance and quality control for PET/CT imaging. The activity and target outcome that is expected through group discussions are the establishment of radiation protection and performance evaluation of PET/CT.

Group members drafted the guideline on the performance evaluation of PET scanner and CT scanner, named “guideline for radiation protection and performance evaluation of PET-CT imaging equipment”. This document is expected to be utilized effectively for the improvement of QA/QC in the developing countries.

Group 2 - Radiation Safety and PET Radiopharmaceuticals

The theme for Group 2 is the QA/QC for PET radiopharmaceuticals, radiation safety for cyclotron and production of 18F-FDG. The activity and target outcome that is expected through group discussions are the establishment of guidelines for the cyclotron performance, 18F-FDG production and QA/QC for 18F-FDG.

Group members discussed about the contents of the guideline. In the result, they agreed that Malaysian representatives were going to finalize the guideline based on the Japanese reference of the production and QA/QC of FDG, combining the conditions of member countries.

Group 3 - Clinical Diagnosis

Group 3 has the theme of publication of case review in clinical PET and thus the group hopes to introduce the FNCA case review system for clinical PET.

They expect the FNCA case review system will be utilized for not only the education item of relevant parties but also the one promoting better understanding of the availability of PET among peoples.

Therefore, they decided in the workshop to add the academic description to every case for the better utilization of users.

The collection of the PET data was continued after the workshop and finally achieved the target value, 100 cases in March, 2009.

Figure a : PET-CT shows an intense brown fat uptake Figure b: Repeat PET-CT - no brown fat uptake over the neck region after the administration of muscle relaxant
Figure a : PET-CT shows an intense brown fat uptake Figure b: Repeat PET-CT - no brown fat uptake over the neck region after the administration of muscle relaxant

Recommendations

Members of the 3rd FNCA workshop on the Applications of Cyclotron and PET in Medicine have agreed on the following recommendations:

This FNCA project to be extended to include further expansion of the existing scope.

To include preparing the guideline for radiation safety aspect in Cyclotron and PET radiopharmaceutical production.

To include pre-installation and acceptance criteria for Cyclotron.

To develop the Quality Assurance guidelines in all sub groups.

To carry out surveillance on personal exposure dose in PET/CT and Cyclotron facilities for optimization.

Open seminar

Open Seminar was held from January 8 to 9, 2009.

The authorities from Malaysia made 10 presentations, China made 2, and Japan made 3 on the several phases of the nuclear medicine including advanced PET technology and shared a lot of information with the audience.

There were almost one hundred participants including lectures at this event.

Participants of Open Seminar Seine of Open Seminar
Participants of Open Seminar Seine of Open Seminar

Minutes of
FNCA2008 Workshop
on Cyclotron and Positron Emission Tomography (PET) in Medicine
Jan. 6-10, 2009 Kuala Lumpur, Malaysia

1. Opening Session

Dr. Muhd Noor Muhd Yunus, Deputy Director General representing Director General of Malaysian Nuclear Agency officiated the 3rd FNCA Workshop on the Application of Cyclotron and PET in Medicine held from 6th - 8th January 2009 at the Best Western Premier Seri Pacific Hotel, Kuala Lumpur. The workshop was jointly organized by Malaysian Nuclear Agency, Ministry of Science, Technology and Innovation, Malaysia (MOSTI) and Ministry of Education, Culture, Sports, Science & Technology (MEXT) of Japan. Dato' Dr. Mohamed Ali Abdul Khader as the Malaysian Project Leader gave welcoming remarks at the opening session. Secondly, on behalf of MEXT, Prof. Keigo ENDO, project leader of Japan, made his remarks and emphasized the significance of this FNCA workshop.

Delegates representing FNCA member countries from People's Republic of China, Japan, Philippines, Malaysia, Thailand, Indonesia and Vietnam attended the workshop.

2. Presentation

This session was chaired by Dr. Zulkifli Mohamed Hashim of Malaysia Nuclear Agency who introduced Dr. Muhd Noor Muhd Yunus as the newly appointed FNCA Coordinator for Malaysia. Dr. Muhd Noor Muhd Yunus introduced the FNCA activities in nuclear medicine, past, present and future status. It is then followed by presentation from Dato' Dr. Mohamed Ali Abdul Khader on the Overview on the Current Situation of Nuclear Medicine in Malaysia and then continued to brief the participants on the objectives and the expected outcome from the workshop. He stressed the importance of finalizing and preparation of the guidelines during this workshop and also reminded all participating member countries that all guidelines should be ready for compilation before mid of February 2009.

3. Group Discussion

The participants were divided into three groups.

  • Group 1 - Instrumentation
    Chairperson: Dr. Noriah Jamal (Malaysia)
    Participants: Prof. Dr. Ahmad Zakaria (Malaysia)
    Assoc. Prof Dr. Wan Ahmad Kamil Abdullah (Malaysia)
    Mr. Ng Aik Hao (Malaysia)
    Mr. Mohd Aminuddin Said (Malaysia)
    Dr. Hideo Muruyama (Japan)
    Prof. Dr. Chen Shengzu (China)
    Assoc. Prof. Dr. Rujaporn Chanachai (Thailand)
    Mr. Tran Ngoc Toan (Vietnam)
    Mr. Alexis Tiongson De Leon (Philippines)
    The theme for Group 1 is radiation safety, quality assurance and quality control for PET/CT imaging. The activity and target outcome that is expected through group discussions are the establishment of radiation protection and performance evaluation of PET/CT.
  • Group 2 - Radiation Safety and PET Radiopharmaceuticals
    Chairperson: Dr. Zulkifli Mohd. Hashim (Malaysia)
    Participants: Dato' Dr. Rehir Dahalan (Malaysia)
    Dr. Kazutoshi Suzuki (Japan)
    Mr. Akihiro Morita (Japan)
    Mr. Takehiko Kato (Japan)
    Prof. Dr. Fan Wo (China)
    Ms. Supaporn Sawadjoon (Thailand)
    Mr. Nguyen Cong Duc (Vietnam)
    Ms. Eva Hyacinth Torres (Philippines)
    Mr. Syed Asraf Fahlawi Wafa S.M. Ghazi (Malaysia)
    Mr. Azahari Kasbollah (Malaysia)
    Mr. Suharzelim Abu Bakar (Malaysia)
    The theme for Group 2 is the QA/QC for PET radiopharmaceuticals, radiation safety for cyclotron and production of 18F-FDG. The activity and target outcome that is expected through group discussions are the establishment of guidelines for the cyclotron performance, 18F-FDG production and QA/QC for 18F-FDG.
  • Group 3 - Clinical Diagnosis
    Chairperson: Dato' Dr. Mohamed Ali Abdul Khader (Malaysia)
    Participants: Prof. Dr. Keigo Endo (Japan)
    Prof. Dr. Dang Yaping (China)
    Assoc. Prof. Dr Pawana Pusuwan (Thailand)
    Dr. Kardinah (Indonesia)
    Dr. Gerard Fabian de Leon Goco (Philippines)
    Dr. Fadzilah Hamzah (Malaysia)
    Group 3 has the theme of publication of case review in clinical PET and thus the group hopes to introduce the FNCA case review system for clinical PET.

4. Group Presentation

Dr. Noriah Jamal presented on behalf of group 1.

Dr. Zulkifli Mohd Hashim presented on behalf of group 2.

Dato' Dr. Mohamed Ali Abdul Khader presented on behalf of group 3.

5. Conclusions

Members of the 3rd FNCA workshop on the Applications of Cyclotron and PET in Medicine have agreed on the following:

  1. To compile all necessary documents and submit to Malaysian project leader according to each group's work plan, recommendation and conclusion latest by 20th February 2009.
  2. Malaysian counterpart of the project will act as the secretariat to compile documents from each sub-group. Discussions through e-mail should be done continuously. The project leader shall review, finalize and approve the documents and send to Malaysian Nuclear Agency for final setting and binding. The deadline for this task is before 25th February 2009.
  3. All communications regarding the final preparation of the documents shall be channeled to participant who has attended this meeting after their name has been nominated by their FNCA country coordinator.
  4. Group 2 has decided to exclude preparing the guideline for radiation safety aspect in Cyclotron and PET radiopharmaceutical production in this workshop. It was proposed to prepare such guideline in the next phase of the project, if applicable. This conclusion has been accepted and agreed by all members of the workshop.
  5. Group 3 recommended that the category of cases should be extended to include other categories and also to increase the number of cases. This has been accepted and agreed by members of the workshop.

Recommendations:

  1. This FNCA project to be extended to include further expansion of the existing scope.
  2. To include preparing the guideline for radiation safety aspect in Cyclotron and PET radiopharmaceutical production.
  3. To include pre-installation and acceptance criteria for Cyclotron.
  4. To develop the Quality Assurance guidelines in all sub groups.
  5. To carry out surveillance on personal exposure dose in PET/CT and Cyclotron facilities for optimization.

Adoption:

Dr. Gerard Fabian de Leon Goco proposed to accept the minute of the meeting and seconded by all members.

Date: 8th January 2009 at 1145 hrs.


Program of
FNCA2008 Workshop
on Cyclotron and Positron Emission Tomography (PET) in Medicine
Jan. 6-9, 2009 Kuala Lumpur, Malaysia



Program of Workshop
DAY 1 : 6th January 2009 (Tuesday) PRESENTER
8:30 - 9:00 Registration of Participants  
9:00 - 9:15 - Welcoming Remark by Malaysian Project Leader Malaysia
9:15 - 9:30 - Remarks by the representative from FNCA
  Prof. Keigo ENDO
Japan
9:30 - 9:45 - Opening ceremony by
  Director General of Malaysian Nuclear Agency.
Malaysia
9:45 - 10:15 Tea Break  
Chairperson: Nuclear Malaysia
10:15 - 10:30 Introduction to FNCA Activities in Nuclear Medicine Past, Present and Future Status - Dr. Muhd Noor Muhd
  Yunus,
  Nuclear Malaysia
10:30 - 11:00 An overview of the current situation of Nuclear Medicine in Malaysia - Dato' Dr Mohamed Ali
  Abdul Khader, MOH
11:00 - 11:30 Overview of FNCA Project of Application of Cyclotron and Positron Emission Tomography (PET) in Medicine
a. Overall Objective
b. Specific Objectives
c. Expected outcome
d. Expected outputs
e. Activities
f. Resource & Input
g. Workplan 2006-2008
Group 1 - Imaging instrumentation
Establishment of a guideline for the performance measurement of PET.
Group 2 - PET Radiopharmaceuticals
- guidance for cyclotron performance,
- PET radionuclides and
- QA/QC for PET pharmaceuticals.
Group 3 - Clinical Diagnosis
Establishment of case review for the Atlas of Clinical PET in CD form
Dato' Dr Mohamed Ali Abdul Khader, MOH
11:30 - 13:00 Group Discussion All Groups
13:00 - 14:00 Lunch  
14:00 - 15:45 Group Discussion All Groups
15:30 - 15:45 Tea Break  
15:45 - 17:30 Group Discussion All Groups
17:30 End of Day 1  
DAY 2 : 7th January 2009 (Wednesday)
Chairperson: Dr. Zulkifli Mohamed Hashim
9:00 - 9:45 Presentation of progress report of project activities by Group 1 All participants
9:45 - 10:15 Tea Break All participants
10:15 - 11:00 Presentation of progress report of project activities by Group 2 All participants
11:00 - 11:45 Presentation of progress report of project activities by Group 3 All participants
11:45 - 13:00 Group Discussion and Report Writing of each section All participants
13:00 - 14:00 Lunch Break  
14:00 - 17:00 Conclusion, Recommendations and Adoption All participants
17:00 End of Day 2  
DAY 3 : 8th January 2009 (Thursday)
Chairperson: Dato' Dr Mohamed Ali Abdul Khader
8:30 - 10:00 Conclusion, Recommendations and Adoption All participants
10:00 - 10:30 Closing Ceremony Dr. Muhd Noor Muhd Yunus,
FNCA Coordinator for Malaysia
12:30 - 14:00 Lunch  

Program of Open Seminar
1st day Session 1
8th January 2009
Moderator: Dr. Zulkifli Mohd Hashim
LECTURER
14:00 - 14:30 Registration of Participants  
14:30 - 14:45 Opening ceremony by
Director General of Malaysian Nuclear Agency.
Nuclear Malaysia
14:45 - 15:15 An overview of the Current Situation of Nuclear Medicine in Malaysia Dato' Dr. Mohamed Ali Abdul Khader, Malaysia
15:15 - 15:45 Cyclotron in Therapy: Application for Proton Therapy and Boron Neutron Capture Therapy Mr. Yukio KUMATA
Sumitomo Heavy Industries
Japan
15:45 - 16:00 Tea  
  Session 2
8th January 2009
Moderator: Dr. Zulkifli Mohamed Hashim
Nuclear Malaysia
16:00 - 16:30 Radiopharmaceutic Production in a Cyclotron PET-CT Facility:
Experience from Putrajaya Hospital. Progress since 2007
Mr. Suharzelim Abu Bakar,
Hospital Putrajaya.
16:30 - 17:00 Registration of Pharmaceutical Products in Malaysia Mr. Abdullah Hisham Ahmad Yaya,
NationalPharmaceutical Control Bureau, Malaysia
17:00 - 17:30 Advanced concept and technology on PET instrumentation Dr. Hideo MURAYAMA
(NIRS), Japan
2nd day Session 3
9th January 2009
Moderator: Mr. Ng Aik Hao
Ministry of Health, Malaysia
8:30 - 9:00 Advanced Production of PET-Probes for Clinical use Dr.Kazatoshi SUZUKI
(NIRS), Japan
9:00 - 9:30 Regulations in Medical Application of the use of Radioisotopes in Nuclear Medicine Mr. Bazlin Sapin,
Engineering Div., Ministry of Health, Malaysia
9:30 - 10:00 Regulations in Medical Application of the use of Radioisotopes in Nuclear Medicine Prof. Chen Shengzu, China
10:00 - 10:30 Role Physicists in PET/CT Imaging Dr. Noriah Jamal, Nuclear Malaysia
10:30 - 10:45 Tea  
  Session 4
9th January 2009
Application of PET in Clinical Practice ( I )
Moderator: Dato' Dr. Mohamed Ali Abdul Khader
Ministry of Health, Malaysia
10:45 - 11:15 PET/CT in Infections & Inflammation Assoc. Prof
Dr. Abdul Jalil Nordin
Universiti Putra Malaysia
11:15 - 11:45 Regulation in the Transportation and Waste Management of radioisotopes used in Nuclear Medicine Mr. Nik Mohd Faiz Khairuddin, AELB
11:45 - 12:15 Comparison of Brain 18F-FDG PET/CT with MRI Imaging in Epilepsy Prof Dang Yaping, China
12:45 - 14:45 Lunch & Friday Prayers  
  Session 5
9th January 2009
Application of PET in Clinical Practice ( II )
Moderator: Mr. Azahari Kasbollah
Nuclear Malaysia
14:45 - 15:15 Role of PET/CT in Lung Cancer Dr. Fadzilah Hamzah,
Ministry of Health, Malaysia
15:15 - 15:45 PET/CT in Thyroid Disease Dr. Felix Sundram
Malaysia
15:45 - 16:15 Role of PET/CT in Lymphomas Management Dato' Dr. Mohamed Ali Abdul Khader, Malaysia
16:45 - 17:15 Certificate Presentation & Closing Ceremony  



List of Participants
FNCA2008 Workshop
on Cyclotron and Positron Emission Tomography (PET) in Medicine
Jan. 6-10, 2009 Kuala Lumpur, Malaysia

Country Name Affiliation
Japan Prof. Keigo ENDO Chairman and Professor Gunma Graduate School of Medicine, Diagnostic Radiology and Nuclear Medicine
Mr. Takehiko KATO Manager, International Affairs and Research Association Nuclear Safety Research Association (NSRA)
Mr. Akihiro MORITA General Manager, International Sales Sumitomo Heavy Industries, Ltd.
Mr. Yukio KUMATA General Manager, Engineering Dept. Sumitomo Heavy Industries, Ltd.
Dr. Hideo MURAYAMA Team Leader,
National Institute of Radiological Sciences
Dr. Kazutoshi SUZUKI Head
National Institute of Radiological Sciences
China Prof. Dang Yaping Professor
First Affiliated Hospital of the Xi'an Jiaotong University
Prof. Chen Shengzu Professor
Cancer Hospital of Chinese Academy of Medical Sciences
Prof. Fan Wo Professor
Soochow University
Indonesia Ms. Kardinah Head of Department Diagnostic Radiology Dharmais Hospital - National Cancer Center
The
Philippines
Dr. Gerard Fabian de Leon Goco, Active Medical Staff
St Luke Medical Center
Ms Eva Hyacinth Ocampo TORRES PET Junior Radiochemist
St Luke Medical Center
Mr Alexis Tiongson De Leon PET Senior Technologist,
St Luke Medical Center
Thailand Prof. Rujaporn Chanachai Associate Professor, Head of Division of Nuclear Medicine, Faculty of Medicine Siriraj Hospital
Ms. Supaporn Sawadjoon Radiochemist
National Cyclotron and PET Centre, Chulabhorn Cancer Centre
Dr. Pawana Pusuwan Associate Professor
Faculty of Medicine Siriraj Hospital
Vietnam Mr. Nguyen Cong Duc Head of Radiopharmaceutical Section
PET & Cyclotron Unit, Nuclear Medicine Department, Cho Ray Hospital
Dr. Pham Thi Minh Bao Head of Nuclear Medicine Department
Tran Hung Dao General Hospital
Dr. Le Ngoc Ha Deputy Head of Nuclear Medicine Department
Tran Hung Dao General Hospital
Malaysia Yg. Bhg. Dato' Dr. Mohamed Ali Abdul Khader Hospital Pulau Pinang
Prof. Dr. Ahmad Zakaria Universiti Sians Malaysia (USM)
Dr. Zulkifli Mohamed Hashim Malaysian Nuclear Agency
Dr. Noriah Jamal Malaysian Nuclear Agency

Forum for Nuclear Cooperation in Asia